NCT03728842View on ClinicalTrials.gov

Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma

Active, not recruitingOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 4, 2004

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
Melanoma; Renal Cell Carcinoma
Interventions
OTHER

Blood collection for laboratory studies

Peripheral whole blood will be collected

OTHER

Data collection from medical record

Clinical data such as demographics and cancer characteristics, history and treatment will be collected

Trial Locations (1)

46202

Indiana University Simon Cancer Center, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03728842 - Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter